NASDAQ:SEPN Septerna Q1 2025 Earnings Results & Report $41.67 -0.93 (-2.18%) Closing price 04:00 PM EasternExtended Trading$41.64 -0.02 (-0.06%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Septerna missed analyst earnings expectations in its Q1 2025 results, released May 15, 2025. The company reported EPS of -$0.49 versus the -$0.38 consensus estimate, while revenue was $220 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 15, 2025TimeAfter Market ClosesConference Call DateMay 14, 2025Conference Call6:00 PM ET Septerna EPS ResultsActual EPS-$0.49Consensus EPS -$0.38Beat/MissMissed by -$0.11One Year Ago EPSN/AEPS Beat Rate3 of last 8 quartersSepterna Revenue ResultsActual Revenue$220 thousandExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Septerna Q1 2025 Earnings FAQ Did Septerna beat earnings estimates for Q1 2025? Septerna (NASDAQ:SEPN) reported earnings of -$0.49 per share for Q1 2025, missing the consensus estimate of -$0.38. The report was announced on Thursday, May 15, 2025. What was Septerna's revenue for Q1 2025? Septerna reported revenue of $220 thousand for Q1 2025. Septerna Earnings HeadlinesSepterna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript2 hours ago | seekingalpha.comTranscript : Septerna, Inc. Presents at UBS Global Biopharma Conference 2026, Nov-16-2026 02:00 PMNovember 16 at 12:40 PM | marketscreener.comMYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 16 at 1:00 AM | Paradigm Press (Ad)Septerna (NASDAQ:SEPN) Director Sells $3,934,723.80 in StockNovember 16 at 4:08 AM | americanbankingnews.comSepterna FY2026 Earnings Forecast Lowered by HC WainwrightNovember 14 at 2:27 AM | americanbankingnews.comSepterna (NASDAQ:SEPN) Downgraded by Wall Street Zen to SellNovember 14 at 1:14 AM | americanbankingnews.comSee More Septerna Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Septerna? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Septerna and other key companies, straight to your email. Email Address About SepternaSepterna (NASDAQ:SEPN) is a clinical-stage biotechnology company developing medicines that target G protein-coupled receptors (GPCRs), a large family of proteins involved in many biological processes. The company is based in South San Francisco, California. Its discovery platform is designed to identify drug candidates that act on GPCRs, including targets that have been difficult to address with conventional drug-development approaches. Septerna is advancing candidates for endocrine, metabolic and other disease areas, with an emphasis on small-molecule medicines. Founded in 2021, Septerna has no marketed products; its work is focused on research and clinical development. The company has also pursued collaborations to apply its GPCR discovery capabilities to additional therapeutic programs.View Septerna ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need? Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.